ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,491 | -81.9% | 14,269 | -71.7% | 0.00% | -80.0% |
| Q2 2023 | $378,737 | +93.7% | 50,431 | +16.6% | 0.01% | +100.0% |
| Q1 2023 | $195,576 | +3.6% | 43,269 | +158.3% | 0.01% | 0.0% |
| Q4 2022 | $188,761 | +4.9% | 16,749 | -24.6% | 0.01% | -37.5% |
| Q2 2022 | $180,000 | -70.8% | 22,211 | -22.6% | 0.01% | -78.9% |
| Q4 2021 | $616,000 | +145.4% | 28,678 | +744.0% | 0.04% | +90.0% |
| Q3 2021 | $251,000 | +8.2% | 3,398 | -19.9% | 0.02% | 0.0% |
| Q2 2021 | $232,000 | – | 4,241 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |